Abstract
Diabetic retinopathy is a well recognised complication of diabetes, which tends to progress with poor metabolic control, ultimately requiring laser therapy. Diabetic retinopathy has been found to worsen in patients requiring chemotherapy for other coexistent conditions like Hodgkins lymphoma. We describe a patient who was on treatment for type 2 diabetes for approximately six years from 1994 and had developed advanced non-proliferative diabetic retinopathy, (figure 1A) by the year 2000. These changes remained stable (February 2001, figure 1B). In August 2001 he was diagnosed to have a duodenal carcinoma and within a few months of commencing chemotherapy there were marked improvements to his retinopathy (March 2002, figure 1C). Improvement in diabetic retinopathy following immunosuppressive therapy is not well recognised and further work is required to evaluate the potential benefits of chemotherapeutic agents in the medical management of diabetic retinopathy.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: The British Journal of Diabetes & Vascular Disease
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
